Can an immunotherapy drug stop lung cancer before it starts?
NCT ID NCT03347838
First seen Dec 15, 2025 · Last updated Jun 16, 2026 · Updated 18 times
Summary
This study tests whether nivolumab, a drug that helps the immune system fight cancer, can reverse abnormal cell growth in the airways of current or former heavy smokers. Nineteen participants at high risk for lung cancer received the drug to see if it could improve or clear precancerous lesions. The goal is to prevent lung cancer from developing, but ongoing monitoring is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOBACCO SMOKING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Denver VA Hospital
Denver, Colorado, 80220, United States
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.